0001213900-26-042811 Sample Contracts

Contract
Unsecured Convertible Promissory Note • April 13th, 2026 • BiomX Inc. • Biological products, (no disgnostic substances) • Delaware

THIS NOTE AND ANY SHARES ACQUIRED UPON CONVERSION OF THIS NOTE OR ANY PORTION THEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, (THE “ACT”) OR ANY STATE SECURITIES LAWS, AND MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, HYPOTHECATED, OR OTHERWISE TRANSFERRED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS, OR (B) AN OPINION OF COUNSEL ACCETABLE TO COUNSEL FOR THE ISSUER THAT SUCH REGISTRATION IS NOT REQUIRED AND THAT THE PROPOSED TRANSFER MAY BE MADE WITHOUT VIOLATION OF THE ACT AND ANY APPLICABLE STATE SECURITIES LAW.

View Source
BIOMX INC. PRE-FUNDED COMMON STOCK PURCHASE WARRANT
Security Agreement • April 13th, 2026 • BiomX Inc. • Biological products, (no disgnostic substances)

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, MANDRAGOLA LTD, a company formed under the laws of the State of Israel or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof and until this Warrant is exercised in full but by no later than April 13, 2031 (the “Termination Date”) but not thereafter, to subscribe for and purchase from BIOMX INC., a Delaware corporation (the “Company”), up to NINE HUNDRED TWENTY THREE THOUSAND (923,000) shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). The term

View Source
STOCK PURCHASE & ASSIGNMENT AGREEMENT
Stock Purchase & Assignment Agreement • April 13th, 2026 • BiomX Inc. • Biological products, (no disgnostic substances) • Delaware

This STOCK PURCHASE & ASSIGNMENT AGREEMENT (this “Agreement”) is made and entered into as of April 13, 2026 (the “Effective Date”), by and between BIOMX INC., a Delaware corporation (“Buyer” or “BiomX”) and MANDRAGOLA LTD., a company formed under the laws of the State of Israel (“Seller”or “Mandragola”).

View Source
Contract
Security Agreement • April 13th, 2026 • BiomX Inc. • Biological products, (no disgnostic substances) • New York

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

View Source